Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).
Tsuchida KI, Taneda S, Yokota I, Okada K, Kurihara Y, Yokoyama H, Iwamoto M, Yamazaki K, Ishigaki Y, Manda N, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group). Tsuchida KI, et al. Among authors: yokoyama h. J Diabetes Investig. 2022 Nov;13(11):1834-1841. doi: 10.1111/jdi.13877. Epub 2022 Jul 5. J Diabetes Investig. 2022. PMID: 35735780 Free PMC article.
Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L.
Takahara M, Katakami N, Shiraiwa T, Abe K, Ayame H, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O, Yokoyama H, Matsuoka TA, Shimomura I. Takahara M, et al. Among authors: yokoyama h. Acta Diabetol. 2019 Mar;56(3):309-319. doi: 10.1007/s00592-018-1244-6. Epub 2018 Oct 23. Acta Diabetol. 2019. PMID: 30353354
Variations in the associations of taste-related words with foods in diabetic patients in Japan according to gender, age, and geographical region: a multicenter study conducted in seven regions of Japan.
Takahara M, Shiraiwa T, Abe K, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O, Yokoyama H. Takahara M, et al. Among authors: yokoyama h. Diabetol Int. 2016 Jan 13;7(3):314-320. doi: 10.1007/s13340-015-0252-9. eCollection 2016 Sep. Diabetol Int. 2016. PMID: 30603279 Free PMC article.
Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study.
Hatta M, Fujihara K, Morikawa SY, Takeda Y, Ishii D, Horikawa C, Kato M, Yokoyama H, Kurihara Y, Iwasaki K, Miyazawa K, Yamazaki K, Tanaka S, Maegawa H, Sone H. Hatta M, et al. Among authors: yokoyama h. Diabetes Ther. 2019 Jun;10(3):1133-1138. doi: 10.1007/s13300-019-0610-x. Epub 2019 Apr 3. Diabetes Ther. 2019. PMID: 30945130 Free PMC article.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Cho KY, et al. Among authors: yokoyama h. Diabetes Obes Metab. 2020 Mar;22(3):458-462. doi: 10.1111/dom.13879. Epub 2019 Oct 13. Diabetes Obes Metab. 2020. PMID: 31486230 Free PMC article. Clinical Trial.
2,427 results